Cornus mas (Cornelian Cherry)

Cornelian cherry (Cornus mas) is a heritage fruit rich in anthocyanins, particularly cyanidin-3-galactoside, and iridoid glycosides such as loganic acid, which drive its antioxidant, anti-inflammatory, and cardiometabolic effects. These bioactives modulate oxidative stress pathways, inhibit alpha-glucosidase activity, and improve endothelial function through nitric oxide upregulation.

Origin & History

Cornus mas (Cornelian cherry) is a deciduous shrub or small tree native to Europe and Asia, belonging to the Cornaceae family, with edible fruits historically used in traditional cuisine and folk medicine. The primary source is the fruit, though leaves and other parts are also utilized, with extraction methods including aqueous extracts, crude extracts, and isolation of phytochemicals like anthocyanins and iridoids.

Historical & Cultural Context

Cornus mas has been used for centuries in European and Asian folk medicines (Serbia, Greece, Iran, China) for conditions including diabetes, gastrointestinal disorders, fevers, and kidney diseases. In Iranian traditional medicine, fruits treat intestinal inflammation and heat stroke, while Greek traditions used it for skin conditions and gout.

Health Benefits

• Cardiovascular support: Meta-analysis showed reductions in systolic and diastolic blood pressure by -9 mm Hg each (moderate evidence from multiple studies)
• Blood sugar regulation: Clinical trials in type 2 diabetic patients showed trends of improved sugar levels and insulin secretion (preliminary evidence, confirmatory trials needed)
• Lipid profile improvement: Studies demonstrated improvements in lipid profiles and apolipoprotein status in hyperlipidemic patients (preliminary clinical evidence)
• Anti-inflammatory effects: Reduced vascular inflammation markers in clinical trials, attributed to antioxidant phenolic compounds (preliminary evidence)
• Metabolic health: Improvements in anthropometric measures and metabolic parameters in high-risk groups including MAFLD and postmenopausal women (moderate evidence from meta-analysis)

How It Works

Cyanidin-3-galactoside and other anthocyanins in Cornus mas scavenge reactive oxygen species and inhibit NF-κB signaling, reducing pro-inflammatory cytokine production including TNF-α and IL-6. Iridoid glycosides such as loganic acid inhibit intestinal alpha-glucosidase and alpha-amylase enzymes, slowing carbohydrate digestion and blunting postprandial glucose spikes. Additionally, anthocyanin metabolites stimulate endothelial nitric oxide synthase (eNOS), promoting vasodilation and contributing to observed blood pressure reductions.

Scientific Research

Clinical trials in type 2 diabetic and hyperlipidemic patients showed trends of improved metabolic markers, though specific PMIDs were not provided in available sources. A recent meta-analysis of supplementation studies (dosages 500 mg/day to 30 g/day dried powder) in high-risk populations reported significant reductions in blood pressure and improvements in cardiometabolic risk factors, though results varied due to differences in study duration and formulations.

Clinical Summary

A meta-analysis of multiple randomized controlled trials found that Cornus mas supplementation significantly reduced both systolic and diastolic blood pressure by approximately 9 mmHg each, representing moderate-quality evidence. Clinical trials in type 2 diabetic patients demonstrated trends toward improved fasting blood glucose and enhanced insulin secretion, though sample sizes have generally been small (typically 40–80 participants) and study durations short (8–12 weeks), limiting conclusive strength. Lipid-profile studies suggest modest reductions in LDL cholesterol and triglycerides, though these findings remain preliminary. Overall, the evidence base is promising but requires larger, longer-duration RCTs to confirm therapeutic dosing and long-term efficacy.

Nutritional Profile

Cornelian cherry (Cornus mas) fruit contains approximately 65-80 kcal per 100g fresh weight. Macronutrients: carbohydrates 9-17g/100g (primarily fructose and glucose), dietary fiber 1.6-3.2g/100g (both soluble and insoluble fractions), protein 1.0-1.5g/100g, fat 0.2-0.6g/100g. Key micronutrients: vitamin C 50-110mg/100g (notably high, comparable to citrus fruits, though bioavailability is moderate due to co-occurring tannins), potassium 180-220mg/100g, calcium 32-45mg/100g, magnesium 12-18mg/100g, iron 1.2-2.0mg/100g (non-heme, absorption limited by polyphenol content), phosphorus 28-40mg/100g. Bioactive compounds: anthocyanins 150-600mg/100g fresh weight (predominantly cyanidin-3-galactoside and cyanidin-3-glucoside, with high oral bioavailability enhanced by the fruit matrix), iridoid glycosides 40-120mg/100g (loganic acid, cornin/verbenalin — relatively stable to digestion), total polyphenols 300-900mg GAE/100g fresh weight, flavonoids including quercetin and kaempferol glycosides at 20-50mg/100g, ellagic acid and ellagitannins at 15-40mg/100g (partially converted to urolithins by gut microbiota). Organic acids: malic acid 1.2-2.5g/100g, citric acid 0.4-1.0g/100g, succinic acid present in minor amounts. Carotenoids: beta-carotene approximately 0.3-0.8mg/100g. Bioavailability notes: polyphenol absorption is estimated at 5-20% depending on gut microbiome composition; iridoids show moderate absorption with urinary excretion detected within 2-4 hours post-ingestion; vitamin C absorption may be partially reduced by tannin binding at high intakes.

Preparation & Dosage

Clinically studied dosages include 500 mg/day to 20 mL/day of extract or 20-30 g/day of dried powder, primarily for cardiometabolic outcomes. No standardized extract dosages based on anthocyanin or iridoid content were consistently reported in trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Hawthorn berry, Bilberry, Alpha-lipoic acid, Chromium, Cinnamon extract

Safety & Interactions

Cornus mas fruit and standardized extracts are generally well tolerated in human studies, with no serious adverse events reported at doses up to 1,000 mg/day of extract for 8–12 weeks. Due to its blood glucose-lowering activity via alpha-glucosidase inhibition, concurrent use with antidiabetic medications such as metformin, sulfonylureas, or insulin may risk additive hypoglycemia and warrants medical supervision. Its blood pressure-lowering properties suggest caution when combined with antihypertensive drugs, as synergistic effects could cause hypotension. Safety data during pregnancy and lactation are insufficient, so use is not recommended in these populations.